BIO-TECHNE CORP's ticker is TECH and the CUSIP is 09073M104. A total of 549 filers reported holding BIO-TECHNE CORP in Q1 2022. The put-call ratio across all filers is 0.27 and the average weighting 0.2%.
About BIO-TECHNE CORP
Bio-Techne Corp is a leading provider of innovative life science research tools and diagnostic solutions. The company is headquartered in Minneapolis, Minnesota, and has operations in over 50 countries worldwide. Bio-Techne's products and services are used by researchers and clinicians in a wide range of fields, including cancer research, stem cell research, and immunology.
Bio-Techne's success is due in large part to its commitment to innovation and customer service. The company invests heavily in research and development, and has a team of over 1,000 scientists working to develop new products and technologies. Bio-Techne also has a strong focus on customer service, with a dedicated team of technical support specialists available to assist customers with any questions or issues they may have.
In addition to its research tools and diagnostic solutions, Bio-Techne also has a growing portfolio of clinical diagnostic products. The company's Exosome Diagnostics subsidiary is a leader in the development of liquid biopsy tests for cancer diagnosis and monitoring.
Bio-Techne's leadership team is comprised of experienced executives with a track record of success in the life sciences industry. Charles Kummeth, the company's CEO, has been with Bio-Techne since 2013 and has overseen significant growth and expansion during his tenure.
Overall, Bio-Techne is a company with a strong reputation for innovation, customer service, and leadership in the life sciences industry. With a growing portfolio of products and services, the company is well-positioned for continued success in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,485 | -16.8% | 36,508 | -0.2% | 0.02% | -20.0% |
| Q2 2023 | $2,986 | +19.5% | 36,578 | +8.6% | 0.02% | +17.6% |
| Q1 2023 | $2,498 | -12.0% | 33,675 | -1.7% | 0.02% | -19.0% |
| Q4 2022 | $2,839 | -99.9% | 34,260 | +326.0% | 0.02% | +16.7% |
| Q3 2022 | $2,284,000 | -16.1% | 8,043 | +2.4% | 0.02% | -10.0% |
| Q2 2022 | $2,723,000 | -29.9% | 7,856 | -12.4% | 0.02% | -13.0% |
| Q1 2022 | $3,884,000 | -28.0% | 8,969 | -15.4% | 0.02% | -17.9% |
| Q4 2021 | $5,393,000 | -16.3% | 10,599 | -20.3% | 0.03% | -20.0% |
| Q3 2021 | $6,445,000 | +2.3% | 13,300 | -5.0% | 0.04% | -10.3% |
| Q2 2021 | $6,303,000 | +1732.3% | 13,999 | +1455.4% | 0.04% | +1850.0% |
| Q1 2021 | $344,000 | +35.4% | 900 | +12.5% | 0.00% | 0.0% |
| Q4 2020 | $254,000 | -76.7% | 800 | -85.5% | 0.00% | -80.0% |
| Q1 2019 | $1,092,000 | -77.0% | 5,500 | -83.2% | 0.01% | -76.7% |
| Q4 2018 | $4,747,000 | +20.9% | 32,800 | +26.2% | 0.04% | +13.2% |
| Q1 2018 | $3,927,000 | -3.8% | 26,000 | -17.5% | 0.04% | +8.6% |
| Q4 2017 | $4,081,000 | -13.4% | 31,500 | -19.2% | 0.04% | -18.6% |
| Q3 2017 | $4,715,000 | +2.9% | 39,000 | 0.0% | 0.04% | -2.3% |
| Q2 2017 | $4,583,000 | -52.3% | 39,000 | -58.8% | 0.04% | -2.2% |
| Q1 2017 | $9,616,000 | +81.2% | 94,600 | +83.3% | 0.04% | -29.7% |
| Q4 2016 | $5,306,000 | -23.0% | 51,600 | -18.0% | 0.06% | -14.7% |
| Q3 2016 | $6,888,000 | -5.9% | 62,900 | -3.1% | 0.08% | -8.5% |
| Q2 2016 | $7,319,000 | +6.2% | 64,900 | -11.0% | 0.08% | +6.5% |
| Q1 2016 | $6,891,000 | -19.7% | 72,900 | -22.5% | 0.08% | -30.6% |
| Q4 2015 | $8,583,000 | – | 94,100 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 46,500 | $16,119,000 | 8.75% |
| Montanaro Asset Management Ltd | 93,950 | $32,567,000 | 4.90% |
| Jackson Square Partners, LLC | 556,157 | $192,786,000 | 4.50% |
| STONE RUN CAPITAL, LLC | 22,405 | $7,767,000 | 3.91% |
| Ownership Capital B.V. | 655,654 | $227,276,000 | 3.90% |
| Brown Capital Management | 839,587 | $291,034,000 | 3.90% |
| Sandhill Capital Partners LLC | 97,382 | $33,757,000 | 3.61% |
| DF DENT & CO INC | 684,026 | $237,111,000 | 3.34% |
| Westwind Capital | 27,946 | $9,687,000 | 3.17% |
| MAIRS & POWER INC | 655,930 | $227,371,000 | 2.72% |